Siemens Healthineers CEO Indicates Potential Sale of Diagnostics Division by 2030

Written by Emily J. Thompson, Senior Investment Analyst

Source: Reuters

Updated: Nov 17 2025

0mins

Source: Reuters

Divestment Consideration: Siemens Healthineers is contemplating the divestment or spin-off of its diagnostics division by 2030, pending a review of its structure, although no discussions with potential buyers have occurred yet.
Financial Growth Targets: The company aims for annual revenue growth of 6-9% from its Imaging and Precision Therapy divisions from 2027 to 2030, while the diagnostics division is expected to achieve mid-single-digit growth.
Tariff Offset Strategy: Siemens Healthineers plans to fully offset an annual U.S. tariffs burden of approximately 400 million euros by 2028 through enhanced productivity and price increases.
Siemens Stake Reduction: Siemens intends to reduce its stake in Healthineers from 67% to 37% or less by transferring shares to its shareholders, with potential further reductions to below 20% in the medium term as it shifts focus to trains and automation technology.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.